Additionally, the IRONOUT HF (Oral Iron Repletion Effects On Oxygen Uptake in Heart Failure) trial demonstrated no beneficial effect of oral iron supplementation on time to death or cardiovascular hospitalization or on primary (peak oxygen uptake) or secondary end-points (NT-proBNP levels and 6-minute walk test) [42]. This evidence concerns the gene NPPB and heart failure.